Trademarkia Logo

Canada

C$
Trademark Search in Canada
MIRAPEUTICS

View On IC.GC.CA

MIRAPEUTICS
ADVERTISED

on 15 Jan 2025

Last Applicant/ Owned by

Abiologics, Inc.

Building 600/700, Suite 7-201,One Kendall SquareCambridge MA 02139

US

Serial Number

2197605 filed on 11th Feb 2022

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

MIRAPEUTICS

Trademark usage description

proteins for use in manufacture pharmaceuticals; proteins for industrial purposes, namely, agriculture, aquaculture, cosmetics, food supplements pro Read More

Classification Information

Class [001]
Proteins for use in manufacture pharmaceuticals; proteins for industrial purposes, namely, agriculture, aquaculture, cosmetics, food supplements

Classification kind code

11

Class [005]
Protein arrays for medical diagnosis purposes; pharmaceutical preparations for the diagnostics or treatment of cancer and hematological diseases and disorders, namely, breast cancer, glioblastoma, non small cell lung cancer, hemophilia, pancreatic cancer, immune system-related diseases and disorders, namely, autoimmune diseases and disorders, multiple sclerosis, immunologic deficiency syndromes, endocrinological diseases and disorders, namely, growth and thyroid disorders, thyroid eye diseases, acromegaly, neuromuscular diseases, namely primary periodic paralysis, glucagonoma, polycystic ovary syndrome, Cushing's syndrome, Graves' disease, metabolic diseases and disorders, namely, diabetes, gout, arthritis, hyperoxaluria, pancreatic insufficiency, phenylketonuria, kidney stones, anemia, obesity, hyperphagia, hyperlipidemia, metabolic syndrome, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, Parkinson's Disease, cerebral palsy, myasthenia gravis, brain injury, spinal cord injury, seizure disorders, neurodegenerative diseases and disorders, namely amyotrophic lateral sclerosis, cardiac diseases and disorders, infectious diseases and disorders, namely, urinary tract infections, respiratory infections, eye infections, topical infections, COVID, HIV, skin and hair diseases and disorders, namely atopic dermatitis and psoriasis, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, namely, acid reflux diseases (GERD), chronic sinusitis, dysphagia, ocular diseases and disorders, age-related macular degeneration, macular edema, sensory diseases and disorders, namely, sensory organ disorder, autism spectrum disorder, attention deficit hyperactivity disorder, schizophrenia, sleep disorders, developmental delay, orthopedic diseases and disorders, respiratory diseases and disorders, pulmonary fibrosis, chronic obstructive pulmonary disease, asthma, cystic fibrosis, reproductive diseases and disorders, gastrointestinal diseases and disorders, namely inflammatory bowel disease, Crohn's disease, ulcerative colitis, short bowel syndrome, bone diseases and disorders, namely osteoporosis, fungal diseases and disorders, namely, fungal skin infections, ringworm, candida infections of mouth, throat, and esophagus, blastomycosis, coccidioidomycosis, histoplasmosis, paracoccidioidomycosis, aspergillosis, murcormycosis, mycetoma; therapeutic pharmaceuticals for the treatment or diagnosis of cancer and hematological diseases and disorders, namely breast cancer, glioblastoma, non-small cell lung cancer, hemophilia, pancreatic cancer, immune system-related diseases and disorders, namely, autoimmune diseases and disorders, multiple sclerosis, immunologic deficiency syndromes, endocrinological diseases and disorders, namely, growth and thyroid disorders, thyroid eye diseases, acromegaly, neuromuscular diseases, namely primary periodic paralysis, glucagonoma, polycystic ovary syndrome, Cushing's syndrome, Graves' disease, metabolic diseases and disorders, metabolic diseases and disorders, namely, namely, diabetes, gout, arthritis, hyperoxaluria, pancreatic insufficiency, phenylketonuria, kidney stones, anemia, obesity, hyperphagia, hyperlipidemia, metabolic syndrome, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, Parkinson's Disease, cerebral palsy, myasthenia gravis, brain injury, spinal cord injury, seizure disorders, neurodegenerative diseases and disorders, namely amyotrophic lateral sclerosis, cardiac diseases and disorders, infectious diseases and disorders, namely, urinary tract infections, respiratory infections, eye infections, topical infections, COVID, HIV, skin and hair diseases and disorders, namely atopic dermatitis and psoriasis, ear or nose or throat diseases and disorders, namely, acid reflux diseases (GERD), chronic sinusitis, dysphagia, ocular diseases and disorders, age-related macular degeneration, macular edema, sensory diseases and disorders, namely, sensory organ disorder, autism spectrum disorder, attention deficit hyperactivity disorder, schizophrenia, sleep disorders, developmental delay, orthopedic diseases and disorders, respiratory diseases and disorders, namely pulmonary fibrosis, chronic obstructive pulmonary disease, asthma, cystic fibrosis, reproductive diseases and disorders, gastrointestinal diseases and disorders, namely inflammatory bowel disease, Crohn's disease, ulcerative colitis, short bowel syndrome, bone diseases and disorders, namely osteoporosis, and fungal diseases and disorders, fungal diseases and disorders namely, fungal skin infections, ringworm, candida infections of mouth, throat, and esophagus, blastomycosis, coccidioidomycosis, histoplasmosis, paracoccidioidomycosis, aspergillosis, murcormycosis, mycetoma

Classification kind code

11

Class [042]
Scientific research, in the fields of biotechnology, pharmaceuticals, oncology, and genetics, pharmaceutical research, medical research; biotechnology research; technical scientific consultation services and product development for others in the field of biotechnology and the development of protein-based pharmaceuticals, diagnostics, biomaterials, industrial reagents, agricultural products, cosmetics, consumer products and nutrition products

Classification kind code

11

Mark Details

Serial Number

2197605

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 31st Oct 2023		Search Recorded
Submitted for opposition 20
on 31st Oct 2023		Examiner's First Report
Submitted for opposition 135
on 29th Jun 2023		Amendment to Application
Submitted for opposition 256
on 15th May 2023		Notification of Possible Opposition Sent
Submitted for opposition 210
on 1st Sept 2022		IR Correction
Submitted for opposition 257
on 14th Jul 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 13th Jul 2022		Formalized
Submitted for opposition 1
on 13th Jul 2022		Created
Submitted for opposition 228
on 11th Feb 2022		International Registration
Submitted for opposition 30
on 11th Feb 2022		Filed